Primary Biliary Cholangitis
We recommend
What situations can arise in PBC treatment with obeticholic acid? Answers provided by case studies from real practice at CKTCH
The Hradec Gastroenterology Days 2023 were traditionally held in March at the Educational Center of the Faculty of Medicine, Charles University, in the area of University Hospital Hradec Králové. The expert program included a lecture by MUDr. Libuše Husová, Ph.D., from the Cardio-surgical and Transplant Surgery Center Brno (CKTCH), who highlighted various situations that can arise during the treatment of primary biliary cholangitis (PBC) with three case studies.
Diagnosis and Management of Therapy for a Breastfeeding Patient with Significant Elevation of Liver Enzymes Postpartum – Interactive Case Study
In the following case study, we present a specific approach to a patient who developed a significant...
Longer survival without liver transplant in patients with PBC treated with OCA?
Obeticholic acid (OCA) is a second-line treatment for patients with primary biliary cholangitis…
Articles on this topic
Journal articles Treatment of liver cirrhosis – actually possibility of ambulant internist
V České republice žije 40 000–60 000 pacientů s jaterní cirhózou a ročně jich v jejím důsledku...
1
2
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Treatment of liver cirrhosis – actually possibility of ambulant internist
- After 20 years, a new treatment option for primary biliary cholangitis arrives
- Key for Patients with PBC are Timely Diagnosis and Assessment of Therapy Effectiveness
- Fecal microbiota transplantation – past, present, and future
- Obeticholic Acid in the Treatment of Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid in Real Practice
- To what extent can the actual level of ALP, ALT, or bilirubin differ from the measured value?
Journal on this topic
Related topic